Κατάλογος ενδεικτικών δημοσιεύσεων του τμήματος Ιατρικής ΑΠΘ σε διεθνή επιστημονικά περιοδικά κατά τα τελευταία 5 έτη.
Serum total adiponectin in nonalcoholic fatty liver disease: a systematic review and meta-analysis..
Metabolism. 60(3), 313-26.
(2011). Serum alpha-fetoprotein in patients with nonalcoholic fatty liver disease..
Eur Rev Med Pharmacol Sci. 17(17), 2411-2.
(2013). Insulin resistance and therapy: cross-talk between phosphatidylinositol-3 kinase and mitogen-activated protein kinase pathways..
Med Hypotheses. 72(5), 610.
(2009). Fatty liver in lipodystrophy: A review with a focus on therapeutic perspectives of adiponectin and/or leptin replacement..
Metabolism. 96, 66-82.
(2019). Adipocytokines and cytokeratin-18 in patients with nonalcoholic fatty liver disease: Introduction of CHA index..
Ann Hepatol. 12(5), 749-57.
(2013). Aromatase inhibitors in post-menopausal endometriosis..
Reprod Biol Endocrinol. 9, 90.
(2011). Nonlinear distribution of adiponectin in patients with nonalcoholic fatty liver disease limits its use in linear regression analysis..
J Clin Gastroenterol. 44(3), 229-30; author reply 230-1.
(2010). Periostin on the road to nonalcoholic fatty liver disease..
Endocrine. 51(1), 4-6.
(2016). Vaspin, resistin, retinol-binding protein-4, interleukin-1α and interleukin-6 in patients with nonalcoholic fatty liver disease..
Ann Hepatol. 15(5), 705-14.
(2016). Metabolic dysfunction-associated steatotic liver disease: Recent turning points for its diagnosis and management..
Metabolism. 155936.
(2024). Helicobacter pylori infection and nonalcoholic fatty liver disease: Time for large clinical trials evaluating eradication therapy..
Helicobacter. 24(3), e12588.
(2019). Noninvasive Liver Fibrosis Tests in Patients with Nonalcoholic Fatty Liver Disease: An External Validation Cohort..
Horm Metab Res. 51(2), 134-140.
(2019). Leptin in health and disease: facts and expectations at its twentieth anniversary..
Metabolism. 64(1), 5-12.
(2015). Peptide Polyagonists for the Treatment of Nonalcoholic Fatty Liver Disease..
Curr Pharm Des. 29(41), 3263-3265.
(2023). The use of demographic, ultrasonographic and scintigraphic data in the diagnostic approach of thyroid nodules..
Exp Clin Endocrinol Diabetes. 117(4), 159-64.
(2009). Systematic review of cases reporting blood extravasation-related complications after thyroid fine-needle biopsy..
J Otolaryngol Head Neck Surg. 39(5), 532-41.
(2010). Adipose tissue, obesity and non-alcoholic fatty liver disease..
Minerva Endocrinol. 42(2), 92-108.
(2017). Sex steroids and sex hormone-binding globulin in postmenopausal women with nonalcoholic fatty liver disease..
Hormones (Athens). 12(3), 405-16.
(2013). Targeted analysis of three hormonal systems identifies molecules associated with the presence and severity of NAFLD..
J Clin Endocrinol Metab.
(2019). Epidemiologic analysis of thyroid fine needle aspiration biopsies over a period of 18 years (1987-2004)..
Exp Clin Endocrinol Diabetes. 116(8), 496-500.
(2008). The effect of zoledronic acid on serum dickkopf-1, osteoprotegerin, and RANKL in patients with Paget's disease of bone..
Horm Metab Res. 41(11), 846-50.
(2009). Non-alcoholic fatty liver disease in women with polycystic ovary syndrome: assessment of non-invasive indices predicting hepatic steatosis and fibrosis..
Hormones (Athens). 13(4), 519-31.
(2014). A novel noninvasive index for nonalcoholic steatohepatitis: a pilot study..
Biomarkers. 18(7), 607-13.
(2013). Clinical complications following thyroid fine-needle biopsy: a systematic review..
Clin Endocrinol (Oxf). 71(2), 157-65.
(2009). Helicobacter pylori and insulin resistance association: not just a myth, not yet a fact..
Saudi J Gastroenterol. 17(6), 425-6.
(2011).